Gene-Editing Therapy Reduced Attacks in Hereditary Angioedema

(MedPage Today) -- A single dose of the CRISPR-based gene-editing therapy NTLA-2002 reduced angioedema attacks and led to sustained reduction in total plasma kallikrein protein levels compared with placebo in patients with hereditary angioedema...